The Scientist6y
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 ...
Medical Device Network on MSN7d
FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B
The US Food and Drug Administration (FDA) has granted clearance to Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B, ...
TMCnet8d
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, further ...
Hosted on MSN3mon
Qiagen locates its global innovation center for infectious diseases in Esplugues (Barcelona)
The German multinational Qiagen has announced this Thursday ... It is a cartridge that, together with a machine, simplifies and speeds up tests using PCR technology. They are used for Covid ...